Excessive activation of inflammatory mediators in patients protein (CRP) may be involved: First, in vitro CRP is able to activate the classical complement pathway on binding to an with sepsis may lead to life-threatening complications such as shock and multiple organ failure. One of the mediator systems appropriate ligand [6] ; second, we have observed a biphasic activation of complement in a baboon model of septic shock, activated during sepsis is the complement system. Patients with sepsis have decreased plasma levels of complement proteins the later phase coinciding with increases of circulating CRP [7] ; and finally, lymphocytes from patients with an IL-2 -induced and increased levels of complement activation products, such as the anaphylatoxins C3a, C4a, and C5a and the terminal sepsis-like syndrome bind complement fragments as well as CRP [8] . complement complexes [1 -3] . Although its precise role in the pathogenesis of sepsis is not clear, activation of complement To investigate the role of CRP in complement activation in vivo, we recently developed sensitive assays for complexes of may contribute to the inflammatory response via the release of cytokines, via activation of clotting and of neutrophils, and via CRP and activated complement proteins (C3b/C3d or C4b/C4d) and showed that circulating levels of these CRP-complement the enhancement of vasopermeability [4] .
Many bacteria activate complement in vitro and are therefore complexes specifically reflect CRP-mediated complement activation [9] . In the study reported here, we used these assays to considered to be the main activators of complement in patients with sepsis. However, several observations indicate that addiinvestigate the role of CRP in the activation of complement in patients with sepsis. tional mechanisms may contribute to complement activation in sepsis: Administration of high doses of interleukin-2 (IL-2) to Furthermore, we attempted to determine the possible ligand for CRP by specifically analyzing circulating levels of complepatients with cancer induces a sepsis-like syndrome, which is accompanied by activation of the classical complement pathment-CRP complexes in patients with pneumococcal infections and by relating levels of complement-CRP complexes with way [5] , demonstrating the existence of a cytokine-driven mechanism of complement activation in vivo. Although the those of secretory type II phospholipase A 2 (sPLA 2 ), an enzyme that may generate ligands for CRP by hydrolyzing membrane precise molecular mechanism of this activation is unknown, some evidence suggests that the acute-phase reactant C-reactive phospholipids.
ologic studies were done in each enrolled patient to establish the and C3d, respectively, were used to capture complexes. These antibodies, anti-C4-1, anti-C4-4, anti-C3-9, and anti-C3-19, presence of infection and the type of microorganism involved as well as its sensitivity to antibiotics. On the basis of results of the capture C4b/C4bi, C4b/C4bi/C4d, C3b/C3bi, and C3b/C3bi/C3d, respectively, and are described elsewhere [9] . CRP-complement bacteriologic examinations, patients were classified as having fever only, local infection, or bacteremic infection.
complexes were detected by biotinylated monoclonal antibodies against CRP. Results were referred to an in-house standard conWe at random selected 88 patients from the fever study to yield 3 groups of patients with comparable size: 29 patients with fever taining a known amount of complexes and expressed as picomolar concentrations of complement fixed to CRP. Levels of all four only, 29 patients who suffered from a local infection, and 30 patients who suffered from a bacteremic infection. In addition to types of complement-CRP complexes in normal healthy volunteers were below the limit of detection (4 pM). these patients of the fever study, 16 patients admitted to the Medical Intensive Care Unit because of septic shock were included in sPLA 2 was determined with a sensitive ELISA as described previously [13] . sPLA 2 levels in healthy volunteers are õ5 mg/L. this study as well. Septic shock criteria used were as described previously [10] . Clinical investigations of all patients included Generation of CRP-complement complexes in vitro. To illustrate the specificity of complement-CRP complexes for CRP-medievaluation of the presence of systemic inflammatory response syndrome or septic shock [10, 11] . Survival was determined at 28 ated activation of complement, we incubated 1 vol of recalcified citrated plasma, to which purified CRP was added to yield a final days after inclusion in case patients who were still in the hospital. Patients discharged from the hospital during the follow-up period concentration of 100 mg/L, with 1 vol of Escherichia coli (0.75 1 10 10 bacteria/mL, final concentration) [14] or lysophosphatidylwere classified as survivors.
Bacteriologic studies. At least 2 blood samples for culture choline (lyso-PC; Sigma, St Louis; 0.5 mg/mL, final concentration) in veronal buffer containing 5 mM CaCl 2 and 1 mM MgCl 2 (final from each patient were obtained by venipuncture at time of inclusion in the study. In addition, local cultures were done when indiconcentrations). Recalcified plasma was obtained from healthy volunteers by collecting blood at 10 mM citrate (final concentration); cated, when clinical signs pointed to a local infection. Supplementary blood cultures were collected at times the treating physician blood samples were centrifuged for 15 min at 1300 g, after which CaCl 2 was added to yield a final concentration of 10 mM. The considered necessary.
Blood and local cultures were processed according to standard plasma was then incubated for 15 min at 37ЊC, whereafter the clot was removed by centrifugation at 2000 g for 10 min. The mixture techniques. Blood cultures containing Staphylococcus epidermidis were considered contaminated when only 1 bottle revealed growth of recalcified plasma and complement activator was incubated for 30 min at 37ЊC. C4 and C3 activation during this incubation was and the patient had no indwelling vascular catheters. All other positive blood cultures were considered to indicate bloodstream assessed by measuring the generation of activation products of C4 and C3 (C4b, C4bi, or C4c [C4b/c] and C3b, C3bi, and C3c [C3b/ infection. Local cultures were thought to reflect an infection if the treating physician decided to start or continue antimicrobial therc]) with ELISAs described previously [15] . Furthermore, the formation of complement-CRP complexes in the mixtures was asapy on the basis of culture results.
Collection of blood samples. At inclusion, and 24 and 48 h sessed by use of the assays described above. Statistical methods. The values of the various complement and thereafter, blood samples were collected in EDTA-containing Venoject tubes. Plasma was separated by centrifugation within 15 other parameters measured were abnormally distributed. Therefore, data were expressed as median values of each parameter min after venipuncture and frozen in aliquots at 070ЊC until assayed. From patients with septic shock, blood samples were obobtained in the plasma samples collected during the first 3 days following inclusion. The significance of differences between tained every day until discharge from the intensive care unit or death.
groups was calculated with the Mann-Whitney U test. To investigate a relation between parameters, we used Spearman's rank corAssays. C3a levels were determined by an RIA described previously [12] and expressed as nanomolar concentrations. Levels relation analysis. Statistical significance was designated at the 95% confidence level (two-sided P). of C3a in healthy persons are õ6 nM.
CRP levels were assessed with a sensitive sandwich-type ELISA, in which polyclonal anti-CRP antibodies were used as catching antibodies and a biotinylated monoclonal antibody against
Results

CRP as detecting antibody. Results were related to a standard
Patients. Sixteen patients fulfilling the criteria for septic commercially available (Behringwerke, Marburgh, Germany) and expressed as milligrams per liter. CRP levels in healthy persons shock were included. From the patients without septic shock, are õ3 mg/L. 29 had negative local or blood cultures and were categorized Complement-CRP complexes were determined by a novel as the fever only group; 29 other patients had positive local method described in detail elsewhere [9] . In short, complementbut negative blood cultures and were categorized as the local CRP complexes as well as noncomplexed CRP were purified from infection group; and finally, 30 patients had positive blood plasma samples by a single-step procedure based on the calciumcultures without shock and were categorized as the bacteremic dependent affinity of CRP (and its complexes) for phosphorylchoinfection group. By compiling the patient groups as we did, line-Sepharose beads. In control experiments, it was established the fever only, local infection, bacteremic infection, and septic that this procedure did not induce additional CRP-complement shock groups were considered to represent patients with infeccomplexes or complement activation. Purified complement comtions of increasing severity. Indeed the survival rates decreased plexes were quantified by differential antibody ELISAs. In these ELISAs, four different antibodies, directed against C4c, C4d, C3c, in the successive groups, from 93% in the fever only group, / 9d3d$$ja02
11-19-97 18:46:40 jinfa UC: J Infect 80% in the local infection group, and 77% in the bacteremic ure 2, top). In the absence of CRP, the activation of C3 and C4 by lyso-PC was greatly reduced and comparable to that infection group to 57% in the septic shock group.
Plasma levels of C3a and C-reactive protein. C3a levels observed with buffer alone (data not shown). In contrast, activation of C4 or C3 by E. coli was not influenced by the presence were increased in 83% of the patients. Levels were significantly (P õ .01) higher in patients who died than in patients who of CRP. In the same mixtures, we also measured the formation of complement-CRP complexes. Significant amounts of these survived (table 1) . Similarly, significantly higher levels were found in patients with shock than in patients without shock complexes were observed only when plasma was incubated with lyso-PC in the presence of CRP (see figure 2, bottom; (table 1), whereas levels were similar in the other groups. Median (range) C3a levels were 8.5 (3 -28) nM in the fever only C3d-CRP and C4d-CRP complexes are shown). Thus, activation of complement by E. coli did not induce the formaonly group; 8.9 (4.4 -20) nM in the local infection group; 13.5 (4.8 -57) nM in the bacteremic infection group; and 54 (4 -tion of complement-CRP complexes, even in the presence of elevated CRP concentrations. The generation of activated C4 104) nM in the septic shock group.
CRP levels were also increased in the majority (98%) of the and C3 as well as the formation of complement-CRP complexes was negligible in the mixtures incubated with veronal buffer patients. Patients who died had significantly (P õ .01) higher levels than patients who survived (table 1) ; similarly, patients only. These experiments confirmed our previous observations that complement-CRP complexes are specific indicators for with shock had significantly (P õ .01) higher levels than patients without shock (table 1). Levels were similar in the other CRP-mediated complement activation. groups. Median (range) CRP levels were 41.6 (0.3 -208) mg/ L in patients with fever only; 50 (0.7 -172) mg/L in patients with local infection; 52 (5.9 -205) mg/L in patients with bacteremia; and 367 (57 -1310) mg/L in patients with septic shock. Consistent with a role of CRP in the activation of complement in the patients, CRP correlated significantly with C3a (r Å .55, P õ .001; see figure 1) .
In vitro generation of complement-CRP complexes. We have previously shown that CRP-mediated activation of complement results in the generation of complement-CRP complexes [9] . To illustrate the specificity of the formation of these complexes for CRP-mediated activation of complement, we incubated recalcified plasma containing CRP at a final concentration of 100 mg/L, with E. coli or lyso-PC as described above, and assessed the amount of complement-CRP complexes generated in these samples. Notably, we used recalcified plasma rather than serum because on incubation of the latter with CRP in the absence of activators, higher background activation of C4 and C3 was observed. This is probably due to the fact that serum contains higher levels of phospholipids released from cells damaged during the clotting process.
A representative example of these experiments is shown in figure 2 . Both E. coli and lyso-PC activated complement, as Complement-CRP complexes in the patients. Circulating levels of complement-CRP complexes were elevated in 98% of the patients. C4b-CRP levels were considerably lower than corresponding C4d-CRP levels, whereas C3b-CRP levels were similar to those of C3d-CRP. Levels of C4b-CRP, C4d-CRP, and C3d-CRP were significantly (P õ .01 for all types of complexes) higher in the patients with septic shock than in the other patients. In addition, patients who died had higher levels than did those who survived (table 1) .
The median level of C3d-CRP complexes in the fever only group was 84 pM. The lowest value in this group of patients was found in a patient clinically suspected of diverticulitis (5 figure 3 . Analyzing the data of the plasma concentrations of acute-phase proteins. The prototypical acute-phase reactant is C-reactive protein, whose levels all patients together, levels of complement-CRP complexes appeared to correlate significantly with those of C3a (C3d-CRP may increase up to 1000-fold. In vitro, a number of functional properties have been ascribed to CRP, including its capacity complexes and C3a: P õ .001; r Å .59) and CRP (C3d-CRP complexes and CRP: P õ .001, r Å .76).
to activate the classical complement pathway [16, 17] . In the present study, we show that levels of C3a significantly correlate Complement-CRP complexes in patients with pneumococcal infections. As CRP is known to bind to C-polysaccharide of with levels of CRP in patients with sepsis. Moreover, we report the presence of increased plasma levels of complement-CRP pneumococci, we studied the course of CRP and complement parameters in detail in the patients infected by these bacteria.
complexes in these patients, thereby providing evidence that in clinical sepsis, CRP mediates activation of complement. In 5 patients, a pneumococcal infection was documented. Complement-CRP complex levels of these patients did not signifiActivation of complement via the classical pathway results in the exposure of an internal thioester in C4 and C3 [18] . cantly differ from those of the other patients, ranging from 5 to 57 pM for C4b-CRP, 83 to 672 pM for C4d-CRP, and 110
These thioesters have the capacity to react with any nearby hydroxyl or amino group. The rapid inactivation of the exposed to 522 pM for C3d-CRP complexes.
Relation of C3a, CRP, and CRP-complement complexes to thioester by the large excess of water molecules present in plasma and the interstitial fluid considerably limits the fixation sPLA 2 . sPLA 2 levels were elevated in 98% of the patients. Levels of sPLA 2 in patients who died were higher than those of C4 and C3 to proteins other than the activator. Demonstration of complement-CRP complexes in biologic fluids could in patients who survived. Moreover, the levels in patients with septic shock were significantly (P õ .01) higher than in patients therefore provide a means to assess CRP-mediated activation of complement in vivo. Indeed, complement-CRP complexes without shock (table 1). The median (range) sPLA 2 levels in patients with fever only were 77 (3 -1250) mg/L, in patients are generated during CRP-mediated complement activation in with local infection were 193 (4 -1250) mg/L, and in patients vitro [19, 20] . with bacteremic infection were 309 (15 -1250) mg/L. In paIt has been shown that C3 may fix to IgG during activation tients with septic shock, the median value was 943 (52 -2053) induced by non-immunoglobulin activators [21] . It was, theremg/L. sPLA 2 correlated significantly with CRP (r Å .74; P õ
fore, essential to demonstrate specificity of complement-CRP .001), C3a (r Å .49; P õ .001), and C3d-CRP (r Å .59; P õ complexes for CRP-mediated activation of complement. Using .001). A plot of the correlation between C3d-CRP complexes recently developed assays, we studied the formation of CRPand sPLA 2 is shown in figure 4 . complement complexes under a number of conditions and found that, in vitro, Ç1% -5% of activated C4 and C3 will fix Discussion to CRP during CRP-mediated complement activation. CRPThe release of cytokines, such as IL-1, tumor necrosis factor, complement complexes were not generated when complement and IL-6, during an inflammatory response induces changes in was activated by aggregated human immunoglobulin, even in the presence of acute-phase concentrations of CRP [9] . Similarly, these complexes were not formed during activation of complement by E. coli, even in the presence of elevated CRP concentrations (see figure 2) . Furthermore, increased plasma levels of complement-CRP occurred in patients 3 days after the implantation of a renal allograft, but these complexes did not increase during classical pathway activation induced by a bolus injection of monoclonal antibody OKT3 (used to prevent transplant rejection), even though these patients had increased CRP levels [9] . Taken together, these data indicate that circulating levels of complement-CRP complexes are specific indicators for CRP-mediated complement activation and do not increase aspecifically following complement activation by activators other than CRP. Nearly all patients had increased plasma levels of complement-CRP complexes. In all cases, both C3d-CRP and C4d-CRP complexes were increased, as was expected considering that CRP activates the classical complement pathway. In addition, most patients also had similar plasma levels of C3b-CRP. However, C4b-CRP complexes were Ç10-fold lower than C4d-CRP complexes. In vitro, we have observed rapid cleavage of Studies in animal models have yielded conflicting results regarding the role of complement in the pathogenesis of sepsis. C3b bound to CRP [9] . Thus, the observed increases of the various types of CRP-complement complexes in the patients Dogs with a genetic C3 deficiency have an impaired clearance of endotoxin and are more susceptible to endotoxin than are with sepsis indicate that this differential regulation of C3b and C4b bound to CRP also occurs in vivo.
healthy animals [32] , suggesting complement to be important for the defense against the infecting microorganisms. On the CRP activates the complement system on binding to an appropriate ligand. Determination of the ligands for CRP in paother hand, inhibition of the biologic effects of C5a in baboons with lethal sepsis attenuates the lethal complications [33] , illustients with sepsis will be a critical step in understanding the physiologic role of CRP-mediated activation of complement.
trating that the proinflammatory effects of complement activation may contribute to the complications of sepsis. Our results Our study does not allow definite conclusions regarding the nature of this ligand but may provide some clues. CRP in indicate that at least part of the complement activation in patients with sepsis is not due to direct interaction with bacteria vitro has been shown to bind to the C-polysaccharide of the pneumococcal cell wall and to products derived from damaged but rather involves CRP and correlates with morbidity and mortality of the patients. Future studies should reveal the role tissue [22] . The interaction between CRP and pneumococci is likely relevant in vivo, since mice transgenic for human CRP of this CRP-mediated complement activation in the pathogenesis of sepsis, that is, whether this route is merely a marker of are protected against infections with these microorganisms [23] . We included 5 patients with pneumococcal infections.
infection-associated tissue damage or contributes by itself to morbidity and mortality. These patients had levels of complement-CRP complexes similar to those in patients with other types of infections. This does not exclude a role of CRP-mediated complement activation in the defense against pneumococci but rather indicates that the
